SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Molecular Cancer Therapeutics|2012Cited by 85
Tumor Vasculature Is Regulated by FGF/FGFR Signaling‐Mediated Angiogenesis and Bone Marrow‐Derived Cell Recruitment: This Mechanism Is Inhibited by SSR128129E, the First Allosteric Antagonist of FGFRsPierre Fons, Françoise Bono, Geneviève Gueguen‐Dorbes et al.|Journal of Cellular Physiology|2014Cited by 25
Supplementary Figure 3 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Unknown|2023Cited by 0
Supplementary Table 3 from SAR131675, a Potent and Selective VEGFR-3–TK Inhibitor with Antilymphangiogenic, Antitumoral, and Antimetastatic ActivitiesAntoine Alam, Françoise Bono, Isabelle Blanc et al.|Unknown|2023Cited by 0